Stay updated with breaking news from Kronos Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- DelveInsight's 'Acute Myeloid Leukemia Pipeline Insight – 2023' report provides comprehensive global coverage of available, marketed, and...
Lanraplenib is being evaluated in ongoing Phase 1b/2 trial in combination with gilteritinib in patients with relapsed/refractory FLT3-mutated AML ...
Item 2.02 Results of Operations and Financial Condition. On November 8, 2022, Kronos Bio, Inc. issued a press release providing a corporate update and announcing its financial results for the... | November 9, 2022
Angela Koehler, an associate professor of biological engineering at MIT, has made it her mission to find ways to drug “undruggable” targets. By taking aim at proteins that interact with these targets, she can indirectly disable them or reduce their impact.
RAPT Therapeutics Strengthens Leadership Team with Two New Key Hires - read this article along with other careers information, tips and advice on BioSpace